Testing effectiveness (Phase 2)Study completedNCT01477879What this trial is testingHsv 1 and 2 Gowey Protocol Versus PlaceboWho this might be right forHerpes Naturopaths International 33
Not applicableStudy completedNCT00357812What this trial is testingThe Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)Who this might be right forHerpes Simplex Keratitis University of Ulster 50
Not applicableStudy completedNCT01160081What this trial is testingSeroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella PertussisWho this might be right forViral Hepatitis VaccinesHepatitis ACytomegalovirus+3 more GlaxoSmithKline 3,658
Testing effectiveness (Phase 2)Looking for participantsNCT05580458What this trial is testingSafety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control PopulationWho this might be right forHerpes Zoster National Institute of Allergy and Infectious Diseases (NIAID) 225
Not applicableStudy completedNCT01043081What this trial is testingSexually Transmitted Infections Among African American Women Who Have Sex With WomenWho this might be right forSexually Transmitted InfectionsHIV Infections University of Mississippi Medical Center 300
Testing effectiveness (Phase 2)Study completedNCT02030301What this trial is testingSafety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in AdultsWho this might be right forGenital Herpes Simplex Type 2 Vical 165
Large-scale testing (Phase 3)Study completedNCT00224471What this trial is testingStudy to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex VaccineWho this might be right forHerpes Simplex GlaxoSmithKline 671
Large-scale testing (Phase 3)Study completedNCT00561080What this trial is testingImmunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)Who this might be right forPrevention of : Herpes-Zoster Merck Sharp & Dohme LLC 759
Testing effectiveness (Phase 2)Study completedNCT05683834What this trial is testingTrial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative PersonsWho this might be right forEpstein-Barr Virus InfectionInfectious MononucleosisHerpesvirus National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableStudy completedNCT02270099What this trial is testingEvaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic SubjectsWho this might be right forHerpes Simplex Infections Hologic, Inc. 839
Not applicableStudy completedNCT01460433What this trial is testingProblems With Immune Recovery in the Gut TissueWho this might be right forHuman Immunodeficiency Virus University of Minnesota 21
Not applicableStudy completedNCT02092233What this trial is testingA Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic PatientsWho this might be right forHerpes Luminex Corporation 1,963
Testing effectiveness (Phase 2)Active Not RecruitingNCT06569823What this trial is testingSafety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and OverWho this might be right forShinglesHerpes ZosterVaccine-Preventable Diseases Dynavax Technologies Corporation 764
Testing effectiveness (Phase 2)Study completedNCT00109122What this trial is testingSafety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)Who this might be right forShingles Merck Sharp & Dohme LLC 180
Large-scale testing (Phase 3)Study completedNCT02723773What this trial is testingA Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older AdultsWho this might be right forHerpes ZosterHerpes Zoster Vaccine GlaxoSmithKline 7,539
Not applicableUnknownNCT03180112What this trial is testingThe Association Between Herpes Simplex Viruses and AutismWho this might be right forAutism Spectrum Disorder Assiut University 80
Early research (Phase 1)Study completedNCT05871541What this trial is testingA First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster VaccineWho this might be right forHerpes Zoster (HZ)ShinglesInfectious Disease Immorna Biotherapeutics, Inc. 75
Early research (Phase 1)Ended earlyNCT05701800What this trial is testingEvaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of AgeWho this might be right forHerpes Zoster ModernaTX, Inc. 659
Not applicableUnknownNCT05823779What this trial is testingA 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected SubjectsWho this might be right forHIV DiseaseHerpes Simplex 1Herpes Simplex 2 Global Research Institute 50
Large-scale testing (Phase 3)Study completedNCT01386294What this trial is testingSafety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) InfectionWho this might be right forHIV Prevention CONRAD 2,059